tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

3 Best Stocks to Buy Now, 10/21/2025, According to Top Analysts

3 Best Stocks to Buy Now, 10/21/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Viant Technology (DSP) – Viant Technology is a digital advertising company that helps brands manage and optimize their ad campaigns across channels. Today, B. Riley Securities analyst Zach Cummins maintained a Buy rating on the stock with a price target of $14.5 per share. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 128.98%.

ServiceNow (NOW) – ServiceNow is a cloud software company that provides digital workflow solutions for enterprises. Today, Barclays analyst Raimo Lenschow maintained a Buy rating on the stock with a price target of $1,210 per share. Interestingly, 21 out of the 22 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 28.94%.

Viridian Therapeutics (VRDN) – Viridian Therapeutics is a biotech company focused on developing treatments for rare and serious diseases. On Monday, H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on the stock with a price target of $34 per share. Interestingly, nine out of the 10 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 66.04%. 

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclaimer & DisclosureReport an Issue

1